ArticleScientific reports2021

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks.

Yu-Cheng Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.